Global Longlife Hospital Promoter Sucheta Jani Completes Full Exit

2 min read     Updated on 12 Dec 2025, 10:45 AM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Global Longlife Hospital promoter Sucheta Dhruvkumar Jani has completed her full exit by disposing of her remaining 2,53,000 equity shares on December 26, 2025, reducing her stake from 2.41% to zero. This final transaction, conducted through open market sales, marks the culmination of her systematic divestment strategy and complete exit from the promoter group of the healthcare company.

27062132

*this image is generated using AI for illustrative purposes only.

Sucheta Dhruvkumar Jani, a promoter of Global Longlife Hospital & Research Limited, has completed her full exit from the company by disposing of her remaining 2,53,000 equity shares on December 26, 2025. This final transaction marks the culmination of a series of substantial share sales that began earlier in December, reducing her stake from 18.00% to zero within a month.

Latest Complete Exit Transaction

The final share sale occurred on December 26, 2025, through open market transactions. The disclosure was filed on December 29, 2025, in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This transaction represents the complete disposal of her remaining shareholding in the healthcare company.

Parameter: Final Transaction Details
Shares Sold: 2,53,000 equity shares
Transaction Date: December 26, 2025
Mode of Sale: Open market
Filing Date: December 29, 2025
Stake Before Sale: 2.41%
Stake After Sale: 0.00%

Complete Shareholding Transformation

Following this final transaction, Sucheta Dhruvkumar Jani's ownership position has been completely eliminated. Her shareholding journey in December shows a systematic exit from a significant promoter position to complete divestment.

Metric: Before Final Sale After Final Sale Change
Shares Held: 2,53,000 0 -2,53,000
Voting Rights (%): 2.41% 0.00% -2.41%
Share Capital (%): 2.41% 0.00% -2.41%
Promoter Status: Active Exited Complete Exit

December Exit Summary

The complete exit represents the final phase of Sucheta Jani's divestment strategy. Based on the latest transaction, she has successfully disposed of her entire remaining stake, marking the end of her association as a promoter shareholder of Global Longlife Hospital and Research Limited.

Exit Summary: Details
Final Shares Disposed: 2,53,000 shares
Final Stake Reduction: 2.41%
Transaction Mode: Open market sale
Regulatory Compliance: SEBI Regulation 29(2)
Current Holding: 0.00% (Complete exit)

Company Structure

Global Longlife Hospital and Research Limited maintains its equity share capital structure unchanged following the promoter exit. The company continues its operations in the healthcare sector with shares listed on BSE Limited.

Company Details: Specifications
Equity Share Capital: ₹10.50 crores
Total Shares Outstanding: 1,05,00,000
Face Value per Share: ₹10.00
BSE Scrip Code: 543520
ISIN Code: INE0J2K01014
Sector: Healthcare

Regulatory Compliance

The final disclosure was made in accordance with SEBI regulations governing substantial acquisitions and disposals of shares. Sucheta Dhruvkumar Jani, based in Ahmedabad, Gujarat, filed the necessary documentation with BSE Limited on December 29, 2025, confirming her complete exit from the promoter group. The transaction involved only equity shares with voting rights, with no involvement of warrants, convertible securities, or other instruments.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%-2.92%+2.86%-9.18%-30.39%-84.06%
Global Longlife Hospital & Research
View in Depthredirect
like18
dislike

Global Longlife Hospital Reports Additional Stake Sale by Dhruv Sureshkumar Jani

2 min read     Updated on 12 Dec 2025, 10:45 AM
scanx
Reviewed by
Naman SScanX News Team
Overview

Global Longlife Hospital and Research Limited received another substantial shareholding disclosure from Dhruv Sureshkumar Jani for the sale of 50,000 equity shares under SEBI regulations. This follows his previous sale of 1,00,000 shares, bringing his total divestment to 1,50,000 shares and reducing his stake from 9.52% to 8.10% within a week through sequential open market transactions.

27062103

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital & Research has received another substantial acquisition disclosure from Dhruv Sureshkumar Jani regarding the sale of equity shares under SEBI regulations. Following his previous transaction in December, Jani has executed an additional sale of 50,000 equity shares between December 12, 2025 and December 17, 2025, further reducing his stake in the healthcare company.

Latest Transaction Details

The recent disclosure, filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, shows Jani's continued divestment in Global Longlife Hospital and Research Limited. This latest transaction follows his earlier sale of 1,00,000 shares completed between December 10-11, 2025.

Transaction Parameter Latest Sale Previous Sale
Shares Sold 50,000 equity shares 1,00,000 equity shares
Transaction Period December 12 - December 17, 2025 December 10 - December 11, 2025
Mode of Sale Open Market Open Market
Regulatory Filing SEBI Regulation 29(2) SEBI Regulation 29(2)

Cumulative Shareholding Impact

With the completion of both transactions, Jani's total divestment amounts to 1,50,000 equity shares within a week. His original holding of 10,00,000 shares (9.52% stake) has been reduced through these sequential sales, demonstrating a systematic reduction in his investment in the company.

Shareholding Timeline Shares Held Percentage Holding
Before December Sales 10,00,000 9.52%
After First Sale (Dec 11) 9,00,000 8.57%
After Second Sale (Dec 17) 8,50,000 8.10%
Total Shares Sold 1,50,000 -1.42%

Company Structure and Compliance

Global Longlife Hospital and Research Limited maintains its equity share capital structure at ₹10.50 crores, comprising 1,05,00,000 equity shares of ₹10.00 each. The company continues to trade on BSE under scrip code 543520 with ISIN INE0J2K01014.

Company Details Specifications
Total Equity Capital ₹10.50 crores
Number of Shares 1,05,00,000
Face Value per Share ₹10.00
BSE Scrip Code 543520
ISIN INE0J2K01014
Sector Healthcare

Regulatory Documentation

Both transactions demonstrate full compliance with SEBI's substantial acquisition regulations. Jani, operating from 25 Divine Bunglows, Science City Road, Sola, Ahmedabad, Gujarat, has submitted all required documentation to BSE Limited and the company, ensuring complete regulatory transparency for both sequential transactions. The filings maintain the company's existing capital structure while reflecting the ongoing changes in ownership pattern.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%-2.92%+2.86%-9.18%-30.39%-84.06%
Global Longlife Hospital & Research
View in Depthredirect
like19
dislike
Explore Other Articles